Work

A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies

Year: 2010

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-09-1267

Authors: D. Ross Camidge, Roy S. Herbst, Michael S. Gordon, S. Gail Eckhardt, Razelle Kurzrock, Blythe Durbin, Josephine Ing, Tanyifor M. Tohnya, Jason Sager, Avi Ashkenazi, Gordon Bray, David Mendelson

Institutions: The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, Genentech

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Genentech

OpenAlex ID: W2050693077

FWCI: 7.029

Cites: 29

Cited by: 169

Related to: 10